BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9288867)

  • 1. Successful Direct Adsorption of Lipoproteins (DALI) Apheresis During Pregnancy in an Omani Woman with Homozygous Familial Hypercholesterolemia.
    Al-Dughaishi T; Al-Waili K; Banerjee Y; Sheik S; Al-Sabti H; Al-Zakwani I; Al-Mukhaini S; Al Wahaibi K; Al-Hinai AT; Al-Rasadi K
    Open Cardiovasc Med J; 2015; 9():114-7. PubMed ID: 27006714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Rosiglitazone Release and Low-Density Lipoprotein Removal by Chondroitin Sodium Sulfate/Cyclodextrin/Poly(acrylic acid) Composite Adsorbents for Atherosclerosis Therapy.
    Xiao Y; Xu Y; Liu X; Cheng S; Wei R; Zhao W; Zhao C
    Biomacromolecules; 2024 May; 25(5):3141-3152. PubMed ID: 38687279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis.
    Schröder S; Epple R; Fischer A; Schettler VJJ
    Ther Apher Dial; 2024 Jun; ():. PubMed ID: 38837319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual stimulus-responsive renewable nanoadsorbent for selective adsorption of low-density lipoprotein in serum.
    Guo C; Jiang X; Guo X; Liu Z; Wang B; Du Y; Tian Z; Wang Z; Ou L
    Regen Biomater; 2024; 11():rbae045. PubMed ID: 38845854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre.
    Mickiewicz A; Borowiec-Wolna J; Bachorski W; Gilis-Malinowska N; Gałąska R; Raczak G; Chmara M; Wasąg B; Jaguszewski MJ; Fijałkowski M; Gruchała M
    Cardiol J; 2019; 26(6):669-679. PubMed ID: 30234904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein apheresis in a pediatric patient of familial hypercholesterolemia: Primi experientia from a tertiary care center in North India.
    Dogra K; Goyal A; Khadgawat R; Gupta Y; Rout D; Fulzele PP; Chaurasia R; Coshic P; Chatterjee K
    Asian J Transfus Sci; 2017; 11(1):58-61. PubMed ID: 28316443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein apheresis to treat elevated lipoprotein (a).
    Waldmann E; Parhofer KG
    J Lipid Res; 2016 Oct; 57(10):1751-1757. PubMed ID: 26889050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lipid apheresis in changing times.
    Schuff-Werner P; Fenger S; Kohlschein P
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):7-14. PubMed ID: 22911176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current view: indications for extracorporeal lipid apheresis treatment.
    Schettler V; Neumann CL; Hulpke-Wette M; Hagenah GC; Schulz EG; Wieland E;
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):15-9. PubMed ID: 22528134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of heparin-immobilized PVA and its adsorption for low-density lipoprotein from hyperlipemia plasma.
    Ma KW; Ma L; Cai SX; Wang X; Liu B; Xu ZL; Dai XZ; Yang JY; Jing AH; Lei WJ
    J Mater Sci Mater Med; 2008 Oct; 19(10):3255-61. PubMed ID: 18470702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the feasibility of selective depletion of T lymphocyte subsets by whole blood immunoadsorption cytapheresis.
    Belak M; Valeri CR; Wright DG
    Clin Exp Immunol; 2007 Dec; 150(3):477-86. PubMed ID: 17924969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia.
    Gordon BR
    Curr Atheroscler Rep; 2000 Jul; 2(4):308-13. PubMed ID: 11122759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.
    Bosch T; Schmidt B; Kleophas W; Otto V; Samtleben W
    Artif Organs; 1997 Oct; 21(10):1060-5. PubMed ID: 9335362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.
    Bosch T; Lennertz A; Schmidt B; Fink E; Keller C; Toepfer M; Dräger J; Samtleben W
    Artif Organs; 2000 Feb; 24(2):81-90. PubMed ID: 10718759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results.
    Bosch T
    Artif Organs; 1996 Apr; 20(4):344-5. PubMed ID: 9139622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis.
    Bosch T
    Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of direct adsorption of lipoprotein apheresis: beyond cholesterol reduction.
    Bosch T; Keller C
    Ther Apher Dial; 2003 Jun; 7(3):341-4. PubMed ID: 12924610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood.
    Bosch T; Schmidt B; Kleophas W; Gillen C; Otto V; Passlick-Deetjen J; Gurland HJ
    Artif Organs; 1997 Sep; 21(9):977-82. PubMed ID: 9288867
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.